Injection of composite with bone marrow-derived mesenchymal stem cells and a novel synthetic hydrogel after myocardial infarction: A protective role in left ventricle function
A number of studies have shown that the transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) into the thinned infarct wall improves regional wall motion. In this study, we hypothesized that the injection of biomaterials and MSCs into the infarcted myocardium can preserve left ventri...
Main Authors: | Jinling Chen, Ruiqiang Guo, Qing Zhou, Tao Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-04-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1607551X13003045 |
Similar Items
-
Treatment of heart failure after myocardial infarction with bone marrow-derived mesenchymal stem cells
by: Hong Yu, et al.
Published: (2016-01-01) -
Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial
by: Runfeng Zhang, et al.
Published: (2021-01-01) -
Comparing the effect of bone marrow mono-nuclear cells with mesenchymal stem cells after acute myocardial infarction on improvement of left ventricular function: a meta-analysis of clinical trials
by: Alireza Hosseinpour, et al.
Published: (2022-05-01) -
Injectable hydrogel-based combination therapy for myocardial infarction: a systematic review and Meta-analysis of preclinical trials
by: Han Gao, et al.
Published: (2024-02-01) -
Conductive nanocomposite hydrogel and mesenchymal stem cells for the treatment of myocardial infarction and non-invasive monitoring via PET/CT
by: Ke Zhu, et al.
Published: (2022-05-01)